Third-party Medical Diagnosis Market

Third-party medical testing belongs to the "Medical Diagnostic Service" sub-industry in the "Medical Service" industry. It is a service form that relies on the Independent Clinical Laboratory (ICL) to provide medical testing and diagnostic outsourcing for various medical institutions. It belongs to the branch of the third-party testing industry in the medical field. Medical diagnosis, third-party medical diagnosis, and independent medical laboratory belong to the affiliation relationship.

Third-party Medical Diagnosis Market contains market size and forecasts of Third-party Medical Diagnosis in Global, including the following market information:

• Global Third-party Medical Diagnosis Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global top five companies in 2021 (%)

The global Third-party Medical Diagnosis market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Hematology Testing Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Third-party Medical Diagnosis include Kingmed Diagnostics Group, Dian Diagnostics Group, ADICON, Daan Gene, Hybribio Biotech, Kangmei Biotechnology, BGI Genomics Co.,Ltd and NovogeneCo.,Ltd., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Third-party Medical Diagnosis companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Third-party Medical Diagnosis Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Third-party Medical Diagnosis Market Segment Percentages, by Type, 2021 (%)

• Hematology Testing
• Genetic Disease and Rare Disease Detection
• Infectious Disease Detection
• Tumor Detection
• Neurological Testing and Gynecological Related Testing

Global Third-party Medical Diagnosis Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Third-party Medical Diagnosis Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Community Health Services
• Medical center
• Desease control Centre
• Others

Global Third-party Medical Diagnosis Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Third-party Medical Diagnosis Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Third-party Medical Diagnosis revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies Third-party Medical Diagnosis revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Kingmed Diagnostics Group
• Dian Diagnostics Group
• ADICON
• Daan Gene
• Hybribio Biotech
• Kangmei Biotechnology
• BGI Genomics Co.,Ltd
• NovogeneCo.,Ltd.